Literature DB >> 1570873

Adverse drug reactions in an elderly outpatient population.

J K Schneider1, L C Mion, J D Frengley.   

Abstract

The prevalence of adverse drug reactions (ADRs) in elderly outpatients was investigated, along with factors that might be associated with their occurrence. The medical records of elderly patients attending an interdisciplinary geriatric clinic and a general medical clinic during 1988 were audited to collect a variety of demographic and treatment data and to detect documentation of first-time ADRs. Subjects were classified as having had an ADR if a physician documented this or if a relevant symptom was noted in the record and a score of 1 or above was obtained on the Adverse Drug Reaction Probability Scale. The presence of potential drug interactions was also assessed. The sample size was 463 patients, of whom 332 attended the medical clinic and 131 attended the geriatric clinic. Potential drug interactions were identified in the records of 143 subjects (31%). There were 107 documented ADRs in 97 patients (21%). Of these patients, 86 were noted by the physicians as having had an ADR. Twelve patients were hospitalized as a direct result of an ADR. Significant risk factors for ADRs were attendance in the geriatric clinic, the use of potentially harmful drug combinations, and the use of drugs that require therapeutic monitoring. Patient age and the number of drugs had no association with ADRs. In the elderly population studied, patients with frailty arising from multiple pathologies were more likely to have ADRs than the more robust elderly, even when their therapeutic regimens were simplified.

Entities:  

Mesh:

Year:  1992        PMID: 1570873

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  27 in total

1.  Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.

Authors:  Maria Cristina G Passarelli; Wilson Jacob-Filho; Albert Figueras
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Using computerized data to identify adverse drug events in outpatients.

Authors:  B Honigman; J Lee; J Rothschild; P Light; R M Pulling; T Yu; D W Bates
Journal:  J Am Med Inform Assoc       Date:  2001 May-Jun       Impact factor: 4.497

Review 3.  Causes and problems of nonresponse or poor response to drugs.

Authors:  P Salvà Lacombe; J A García Vicente; J Costa Pagès; P Lucio Morselli
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

4.  Views of older adults on patient participation in medication-related decision making.

Authors:  Vernee N Belcher; Terri R Fried; Joseph V Agostini; Mary E Tinetti
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

5.  A study on drug-drug interactions through prescription analysis in a South Indian teaching hospital.

Authors:  Vijay Kulkarni; Swathi Swaroopa Bora; Sapineni Sirisha; Mohammed Saji; Siraj Sundaran
Journal:  Ther Adv Drug Saf       Date:  2013-08

6.  Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments.

Authors:  Nina Fokter; Martin Mozina; Miran Brvar
Journal:  Wien Klin Wochenschr       Date:  2010-02       Impact factor: 1.704

Review 7.  Drug-related problems in hospitals: a review of the recent literature.

Authors:  Anita Krähenbühl-Melcher; Raymond Schlienger; Markus Lampert; Manuel Haschke; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 8.  Calcium antagonists in the elderly. A risk-benefit analysis.

Authors:  J B Schwartz
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

9.  Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies.

Authors:  R M Martin; P N Biswas; S N Freemantle; G L Pearce; R D Mann
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

10.  Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals.

Authors:  Yurdaguel Zopf; Christina Rabe; Antje Neubert; Eckhart G Hahn; Harald Dormann
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.